Bayer: A Spectacular Breakthrough
Bayer shares have recently been on a roll. For years, the vexing glyphosate dispute weighed down the share price. But now the company has pulled off a real breakthrough. The enthusiasm among investors is palpable. Roughly speaking, the US Supreme Court ruled that Bayer cannot be sued for failing to include cancer warnings. US authorities mandate the labeling requirements. This is a huge victory with far-reaching…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.